Xpeer course: Detection, Prevention and Treatment of Gut Microbiome Dysbiosis

Created 10 September 2021
Updated 27 October 2023

About this article

Created 10 September 2021
Updated 27 October 2023

Synopsis of the course

Alterations in the gut microbiome may be implicated in the pathogenesis of several non-communicable diseases and in the transition of these conditions to chronicity. Many studies have shown links between faecal microbiota composition and disease, including metabolic, inflammatory and neoplastic disorders. However, the exact (if any) causative role that microbiota changes may have in those diseases remains unclear. Thus, there has been little translation of microbiome science into clinical practice so far, especially in the domains of diagnosis and prognosis, due to the lack of supportive evidence for test and treat strategies. Nevertheless, it is becoming clear that developing and maintaining gut microbiota diversity is a novel clinical target for health promotion and disease prevention, and that diet and probiotics are the natural and most efficient way to improve diversity. Unrestricted grant by Biocodex.


You can book a private mentoring session with Professor Guarner on the app!

Who is professor Guarner ?

  • Francisco Guarner Aguilar, MD, PhD, is a gastroenterologist and senior researcher at the Vall d’Hebron Research Institute.
  • He is the author of more than 300 publications in international research journals, many of which are landmark contributions to the field of microbiota and health.
  • In 2020, he was recognized as one of the most influential researchers in the decade of 2010-2020, receiving the Web of Science’s Highly Cited Researchers (Cross Field) distinction.
  • He is a member of the Guidelines Committee of the World Gastroenterology Organisation, the Steering Committee of the International Human Microbiome Consortium, and past member of the Board of Directors on the International Scientific Association for Probiotics and Prebiotics.
  • Conflicts of Interest Statement: Francisco Guarner receives research grants from Abbvie, Takeda and AB-Biotics, and honoraria or consultation fees from Instituto Danone, Sanofi, Biocodex, Actial, Menarini and Ordesa.

What is Xpeer?

Xpeer Medical Education is the first accredited medical education app in the market, with video microlearning engaging videos of just 5 minutes.

With a powerful algorithm to personalize the user experience and the contents as the most popular entertaining streaming platforms, it offers a brand new experience for the continuing education and professional development of the healthcare professionals.

Accredited by the European Union of Medical Specialists, it delivers high quality scientific medical education pieces. On Xpeer, you will find this curriculum on Microbiota and 500 hours of medical education in 2021 in your specialty, technologies and professional and personal skills.

Information on accreditation

The app Xpeer is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide official ECMEC credits recognized officially in 26 countries.

The credits for the users of the module will be 1 European CME credit (ECMEC®) for every hour (60 minutes of actual e-learning excluding introductions etc.) of use, provided that the users have completed a module and have passed the relevant assessment.

Hailed as one of the greatest medical advances of the 20th century, antibiotics have saved millions of lives. But they also have an impact on our microbiota by inducing a dysbiosis. Let’s take a look at this ambivalence role:

The ambivalent role of antibiotics

By destroying the bacteria responsible for infection, antibiotics can also lead…

What is the World AMR Awareness Week?

Each year, since 2015, the WHO organizes the World AMR Awareness Week (WAAW), which aims to increase awareness of global antimicrobial resistance.
Held on 18-24 November, this campaign encourages the general public, healthcare professionals and decision-makers to use antimicrobials carefully, to prevent the further emergence of antimicrobial resistance.

    See also